Most Popular
-
1
Dongduk Women’s University halts coeducation talks
-
2
Defense ministry denies special treatment for BTS’ V amid phone use allegations
-
3
Russia sent 'anti-air' missiles to Pyongyang, Yoon's aide says
-
4
OpenAI in talks with Samsung to power AI features, report says
-
5
Two jailed for forcing disabled teens into prostitution
-
6
Trump picks ex-N. Korea policy official as his principal deputy national security adviser
-
7
South Korean military plans to launch new division for future warfare
-
8
Gold bars and cash bundles; authorities confiscate millions from tax dodgers
-
9
Kia EV9 GT marks world debut at LA Motor Show
-
10
Teen smoking, drinking decline, while mental health, dietary habits worsen
[THE INVESTOR] Dong-A Socio Holdings announced Aug. 23 that it has decided on a 177.2 billion won (US$158.4 million) capital increase to take over its affiliate ST Pharm, an active pharmaceuticals ingredient company.
In a tender offer to take over the company, it will purchase 3.3 million stocks from ST Pharm stakeholders and in turn issue new stocks of the holding company for them. A total of 989,887 shares will be issued at 178,989 won per share.
By Hwang You-mee (glamazon@heraldcorp.com)
In a tender offer to take over the company, it will purchase 3.3 million stocks from ST Pharm stakeholders and in turn issue new stocks of the holding company for them. A total of 989,887 shares will be issued at 178,989 won per share.
By Hwang You-mee (glamazon@heraldcorp.com)
